Wahiduzzaman, M., A. Yasmin, M. Shahriar Hossain, R. Dhar, and M. M. Haider. “Efficacy and Safety of Empagliflozin (SGLT2 Inhibitor) in Bangladeshi Patients With Type 2 Diabetes Mellitus”. International Journal of Research in Medical Sciences, vol. 13, no. 12, Nov. 2025, pp. 5150-4, doi:10.18203/2320-6012.ijrms20253934.